TRANSCRIPT — The Cells Segment aired 7 June 2155, 21:30 GMT. Hosted by Dr. Millie Saunders. Produced from Luna University campus broadcast facilities.
[THEME MUSIC — “Orbital” by the Luna University Electroacoustic Ensemble — FADES UNDER]
SAUNDERS: Welcome back to The Peer Review. I’m Millie Saunders. This is The Cells. From Luna University.
Tonight: four stories that together paint a picture of where biomedicine stands in mid-2155. Cryosleep hit ten years. Black blood reached two hundred thousand people. Dome 2 grew soil from rock. And Dome 4 just made it possible to scan an asteroid for life in under a minute.
Let’s start with the coldest one.
1. Ten Years Asleep
In 2143, Dr. Sofia Russo opened recruitment for Dome 4’s first human cryosleep trials. Four tiers: one year, two, five, ten. Every applicant went through a full informed consent process. Russo was explicit: twelve years of primate data, zero years of human data, about to become some years of human data. Compensation continued regardless of outcome. Insurance covered the outcome itself.
Two years ago, in 2153, the ten-year cohort woke up.
The results have been circulating informally since then — no paper yet, which itself is unusual for Dome 4 and has drawn comment. But what’s reached the science press amounts to this: the ten-year subjects were revived successfully, with cognitive assessments within baseline, and biological aging during dormancy measured as effectively frozen. Not slowed. Frozen. Vitrification at the cellular level, full metabolic arrest, clock stopped.
What makes this possible is not Russo’s 2131 protocol. That protocol — the one that revived a chimpanzee after two years — was already obsolete by the time human trials opened. The Kowalczyk enzyme from 2141, the D-chiral CPA-degrader sourced from an Enceladus hydrothermal vent chemotroph, broke the revival ceiling from two years to eight in primates. But the real shift came in the early 2150s, when stasis protocols moved beyond passive perfusion washing entirely.
The current protocol embeds synthetic chiral nanobots and mirror-enzymes directly into the cryoprotectant cocktail. Because they’re mirror-image molecules — D-chiral rather than the L-chiral that all terrestrial biology uses — normal human metabolism ignores them completely during dormancy. The body doesn’t recognize them. The immune system doesn’t flag them. They circulate silently, inert, for the entire duration of stasis.
And then, on rewarming, they trigger. A designed cascade activates and clears vitrification toxins — the cryoprotectant breakdown products that Russo spent her career fighting — in under four hours.
Four hours. The classic “minimum standard” post-revival hangover — the period Russo herself described in 2131 as “you will feel like you died and someone dragged you back” — was forty-eight to seventy-two hours. Now it’s an afternoon. Subjects wake up, clear their system, and are cognitively testable before dinner.
No paper has been published. All of this has reached us through news reports and conference presentations. And that timing may not be accidental. Nova Biosciences has filed a lawsuit against Dome 4 alleging that the chiral nanobot delivery architecture reuses proprietary technology Nova originally developed for targeted radioprotective drug delivery — technology Dome 4 had access to under a collaborative agreement that, per Nova’s filing, did not extend to cryosleep applications. Dome 4 has not commented. The case is pending before the Luna Interplanetary Court.
For the moment, the practical upshot is this: human cryosleep works at ten years, with aging frozen and revival hangover compressed to four hours. The Ark, still under construction at Pallas, was designed as a generation ship whose inhabitants would live out the journey awake. The equation that made that decision rational — that cryosleep wasn’t ready — is now in question. The Ark’s first passengers are years from departure. The biology is moving faster than the ship.
2. Dirt from Rock
Which brings us to the second question: if you’re building a closed-loop ecosystem for a century-long voyage, where does your soil come from?
Until April, the answer was Earth. The Cradle changed that.
Dr. Lars O’Connor — former commander of UNS Canteloupe, now seventy-four years old and finally doing the work he trained for — published the Cradle paper in April with the Dome 2 Mycological Ecology Group. The headline: after sixty-eight years, a 100-square-meter sealed environment at Dome 2 has converted lunar regolith into living soil that sustains fourteen crop species, six fungal phyla, and produces 2.3 liters of oxygen per square meter per day with zero external inputs. The loop is closed. The soil is real.
The implications for the Ark are immediate and unspoken in the paper itself. The Ark was always going to need growing substrate — for food, for oxygen cycling, for water retention, for the microbial ecology that keeps a sealed environment stable across generations. The baseline plan imported terrestrial topsoil. Topsoil is heavy. Every kilogram of Earth dirt on the Ark is a kilogram of propellant, a kilogram of structural reinforcement, a kilogram that could have been something else.
O’Connor’s protocol makes the alternative explicit without mentioning the Ark by name: the Cradle’s fungal-first mineralization pathway works on any silicate regolith. Lunar highlands. Martian crust. Ceres. Asteroid rock. The Ark can load inert, sterile, mass-optimized regolith at departure and grow its own soil en route — or, more precisely, let the fungi do it over the first decade of the voyage. The Cradle proves it’s possible. The Ark’s designers now have a choice they didn’t have in March.
O’Connor’s paper closes with a recommendation for a Multi-Generational Biological Systems Fund with minimum fifty-year funding commitments. The Ark is privately funded and doesn’t need UN grants. But the principle is the same: the soil takes as long as it takes, and the only thing that kills it is someone deciding to stop before it’s done.
3. The Scanner That Reads Life
Last week, Dome 4 announced something that will change how the Belt interacts with biology at the most basic level: Homochiral Biosignature Sequencers.
The device is a handheld laser-polarimetry unit that performs Chirality Resonance Spectroscopy — CRS — on surface regolith, ice, or mineral samples. It detects two things simultaneously: homochiral spikes and carbon-12 to carbon-13 isotopic fractionation ratios.
Here’s why that matters. Life on Earth — and, as far as we now know, life on all nine D-chiral worlds mapped by Ibn-Rushd and the Xenobiology Archive — is homochiral. Terrestrial biology uses L-amino acids and D-sugars exclusively. The D-chiral biospheres use D-amino acids and L-sugars. In both cases, life selects one chirality and builds everything from it. Abiotic chemistry doesn’t. An abiotic soup — asteroid organics, hydrothermal vent precursors, interstellar ices — produces a 50/50 racemic mixture of left- and right-handed molecules. Life is a chirality spike. Non-life is a coin flip.
For twenty-five years, confirming the difference required a mass spectrometer the size of a desk, sample destruction, and weeks of lab time. The CRS handheld does it in under a minute, on-site, non-destructively, by measuring the optical rotation of polarized laser light as it passes through a sample. A homochiral biosignature rotates the plane of polarization in one direction. A racemic mixture doesn’t rotate it at all. The device reads the difference and reports: sterile, or alive.
The carbon fractionation measurement adds a second confirmatory axis. Living metabolisms preferentially incorporate carbon-12 over carbon-13. The ratio shifts predictably. Abiotic carbon doesn’t care.
Together, the two measurements give a field answer to a question that previously required a lab: is this asteroid, this ice sheet, this rock — biologically active now, biologically active in the past, or dead since accretion?
The immediate application is mining regulation. Tapping ice on Saturn’s moons — Enceladus, Titan — is no longer a hypothetical. It’s a necessity. The belt and outer system run on water, and Saturn’s moons have more water than the belt has everything. But Saturn is also the D-chirality system: Callisto, the first confirmed D-chiral world, was quarantined in 2104. Ibn-Rushd’s work expanded the catalog to nine worlds across four planetary systems. Some of those worlds are moons of Saturn. The biological status of Saturnian ice is not a settled question.
Under the 2104 Callisto quarantine framework and subsequent UN xenobiological preservation laws, disturbing an active or dormant biological system — even a microbial one, even a D-chiral one — without authorization is a violation carrying sanctions up to and including vessel impoundment and criminal charges. The CRS scanner means a mining operator can determine, on approach, whether an ice deposit is legal to tap or protected. No lab. No weeks of waiting. No ambiguity.
Dome 4 has not announced pricing or manufacturing partners. Expect that announcement within months. Every mining operator in the Belt is going to want one, and the UN Office for Colonial Development is going to want them to have one, because the alternative is a quarantine violation at Saturn that no one can claim they didn’t know about.
4. Two Hundred Thousand
One final number. As of last month, the UN Office of Colonial Health confirms that over two hundred thousand people across the settled system now carry MHA-1 — the radioprotective treatment developed by Dr. Klaus Jäger and the Dome 4 hematology group, commonly called Black Blood.
The treatment entered human trials in 2124. It drew 5,278 applicants in its first year. It can be administered for as little as ten UN credits at a public clinic in Guanghan, placing it within reach of most Luna and Belt residents. Recipients report discontinuing all other anti-radiation medication — SVR-3 and its successors — entirely. It works.
What’s new in the 2155 numbers is the germline fraction. Twenty-five percent of recipients — roughly fifty thousand people — carry the heritable variant: MHA-1 expression engineered to pass to offspring. These are not people who took a treatment. These are children born with it. Their bone marrow produces Jäger’s melanized hematocytes from birth. They will never take a radiation drug. They will never need one.
Outro
Four stories. A human being can now sleep for a decade and wake up metabolically unchanged. A hundred square meters of lunar floor breathes on its own. A handheld scanner reads the difference between life and non-life in under a minute. And two hundred thousand people carry blood that laughs at cosmic radiation — a quarter of them from birth.
The graviton is dead. The cells are, quietly, winning.
[THEME MUSIC — FADES IN, THEN OUT]